Yingxu Shi

480 total citations
20 papers, 389 citations indexed

About

Yingxu Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yingxu Shi has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yingxu Shi's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Yingxu Shi is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Yingxu Shi collaborates with scholars based in China and United States. Yingxu Shi's co-authors include Chengwang Xu, Jie Zhu, Hong Jiang, Yi Tie, Hanjiang Fu, Xiaofei Zheng, Zhixian Sun, Zhuoyuan Zhang, Xiulan Su and Bo Yang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Experimental Cell Research.

In The Last Decade

Yingxu Shi

19 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingxu Shi China 8 250 137 43 41 39 20 389
Jialin Yao China 12 218 0.9× 94 0.7× 71 1.7× 30 0.7× 95 2.4× 41 422
Dong Ding China 9 148 0.6× 58 0.4× 48 1.1× 22 0.5× 30 0.8× 14 361
Jinsen Lu China 13 217 0.9× 77 0.6× 35 0.8× 11 0.3× 113 2.9× 18 445
Feipeng Zhao China 10 187 0.7× 151 1.1× 77 1.8× 15 0.4× 54 1.4× 29 377
Rongchen Dai China 8 166 0.7× 48 0.4× 71 1.7× 12 0.3× 34 0.9× 14 300
Qiong Zhou China 13 206 0.8× 119 0.9× 202 4.7× 42 1.0× 36 0.9× 30 503
Nannan Liu China 10 149 0.6× 37 0.3× 90 2.1× 50 1.2× 53 1.4× 23 425
Shan Chen China 11 205 0.8× 80 0.6× 66 1.5× 13 0.3× 24 0.6× 24 475

Countries citing papers authored by Yingxu Shi

Since Specialization
Citations

This map shows the geographic impact of Yingxu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxu Shi more than expected).

Fields of papers citing papers by Yingxu Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingxu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxu Shi. The network helps show where Yingxu Shi may publish in the future.

Co-authorship network of co-authors of Yingxu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yingxu Shi. A scholar is included among the top collaborators of Yingxu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingxu Shi. Yingxu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Hua, et al.. (2025). The progress of miR-205 regulating apoptosis in cancer. Frontiers in Oncology. 15. 1532659–1532659.
2.
Liu, Jiaqi, Guinv Hu, Hua Du, & Yingxu Shi. (2025). Role and potential mechanisms of miR‑100 in different diseases (Review). Oncology Reports. 54(2). 1–14. 1 indexed citations
3.
Zhang, Caihong, et al.. (2024). The role of alternative polyadenylation in breast cancer. Frontiers in Genetics. 15. 1377275–1377275. 2 indexed citations
4.
Guo, Xin, et al.. (2024). Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer. Biomarkers. 29(7). 419–426. 7 indexed citations
5.
Zhang, Caihong, et al.. (2024). miR-192 family in breast cancer: Regulatory mechanisms and diagnostic value. Biomedicine & Pharmacotherapy. 175. 116620–116620. 5 indexed citations
6.
Li, Renyuan, Zhenting Huang, Yong Zhou, et al.. (2023). Histone H3K79 methylation by DOT1L promotes Aurora B localization at centromeres in mitosis. Cell Reports. 42(8). 112885–112885. 5 indexed citations
7.
Ma, Hongdong, Yingxu Shi, Weilin Zhang, et al.. (2021). Open Curettage With Bone Augmentation for Symptomatic Tumors and Tumor-like Lesions of Calcaneus: A Comparison of Bioactive Glass Versus Allogeneic Bone. The Journal of Foot & Ankle Surgery. 60(5). 881–886. 3 indexed citations
8.
Zhou, Yong, Jian Ding, Lei Xiong, et al.. (2020). LRTM1 promotes the differentiation of myoblast cells by negatively regulating the FGFR1 signaling pathway. Experimental Cell Research. 396(1). 112237–112237. 7 indexed citations
9.
Shi, Yingxu, et al.. (2019). [Efficacy of Quercetin-sensitized Adriamycin for Treatment of Refractory Acute Leukemia].. PubMed. 27(4). 1094–1103. 1 indexed citations
10.
Shi, Yingxu, et al.. (2019). Combination of quercetin and Adriamycin effectively suppresses the growth of refractory acute leukemia. Oncology Letters. 18(1). 153–160. 12 indexed citations
11.
Shi, Yingxu, et al.. (2019). LSD1 negatively regulates autophagy in myoblast cells by driving PTEN degradation. Biochemical and Biophysical Research Communications. 522(4). 924–930. 12 indexed citations
12.
Zheng, Yang, Wei Sun, Jing Wu, et al.. (2019). The Effects of UCH-L3 on the Biological Behaviours of Breast Cancer: Correlation with the Expressions of HIF-1α. Journal of Cancer Science & Therapy. 11(2). 1 indexed citations
13.
Shi, Yingxu, Meirong Zhao, Jing Wu, et al.. (2019). Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa).. PubMed. 12(12). 4380–4389. 16 indexed citations
14.
Cai, Zhenyu, Bo Yang, Yingxu Shi, et al.. (2018). High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway. Biochemical and Biophysical Research Communications. 503(2). 428–435. 53 indexed citations
15.
Su, Liya, et al.. (2015). Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway. Acta Pharmacologica Sinica. 36(12). 1514–1519. 33 indexed citations
16.
Ma, Shihui, Yingxu Shi, Yakun Pang, et al.. (2014). Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen. Journal of Hematology & Oncology. 7(1). 71–71. 35 indexed citations
17.
Han, Yanqiu, Hong Yu, Junrui Wang, et al.. (2014). Quercetin alleviates myocyte toxic and sensitizes anti-leukemic effect of adriamycin. Hematology. 20(5). 276–283. 19 indexed citations
18.
Tian, Chen, Yingxu Shi, Jinhong Wang, et al.. (2011). [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model].. PubMed. 19(3). 566–9. 2 indexed citations
19.
Fu, Hanjiang, Yi Tie, Chengwang Xu, et al.. (2005). Identification of human fetal liver miRNAs by a novel method. FEBS Letters. 579(17). 3849–3854. 173 indexed citations
20.
Peng, Jing, et al.. (1993). [Study on the relationship between two second-messenger pathways on the regulation of proliferation and differentiation in MGc 80-3 cells].. PubMed. 26(3). 187–95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jialin Yao Breakdown of academic impact, for papers by Dong Ding Breakdown of academic impact, for papers by Jinsen Lu Breakdown of academic impact, for papers by Feipeng Zhao Breakdown of academic impact, for papers by Rongchen Dai Breakdown of academic impact, for papers by Qiong Zhou Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Shan Chen
Rankless by CCL
2026